AnalystsJoseph Pantginis
Joseph Pantginis's Stock Forecasts

Analyst Ranking
Bottom 1%
#4939 out of 4939 analysts
Average Return
-9.52%
Win Rate
33%302 out of 903
Risk vs Reward
Poor
Good

Joseph Pantginis's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Celldex Therapeutics IncCLDX
+1,183.78%$1.85$23.75
2020-03-26 -
2021-03-26
Buy
Alpine Immune Sciences IncALPN
+694.86%$8.17$64.94
2023-05-11 -
2024-05-10
Buy
Biomea Fusion IncBMEA
+644.47%$4.79$35.66
2022-06-01 -
2023-06-01
Buy
Capricor Therapeutics IncCAPR
+501.06%$2.84$17.07
2023-10-03 -
2024-10-03
Buy
Alpine Immune Sciences IncALPN
+450.59%$11.80$64.97
2023-09-12 -
2024-05-17
Buy

Joseph Pantginis's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Capricor Therapeutics IncCAPR
23Buy$24.00+224.98%Maintains
4 days ago
Travere Therapeutics IncTVTX
1Buy$30.00+77.41%Assumes
15 days ago
Pds Biotechnology CorpPDSB
30Buy$13.00+956.91%Reiterates
15 days ago
Edgewise Therapeutics IncEWTX
1Buy$42.00+201.51%Initiates Coverage On
16 days ago
Viking Therapeutics IncVKTX
32Buy$102.00+222.48%Reiterates
20 days ago
Phio Pharmaceuticals CorpPHIO
2Buy$14.00+480.91%Reiterates
20 days ago
Krystal Biotech IncKRYS
29Buy$240.00+59.56%Reiterates
21 days ago
Cidara Therapeutics IncCDTX
2Buy$53.00-4.19%Maintains
21 days ago
Lexicon Pharmaceuticals IncLXRX
22Buy$4.00+238.98%Reiterates
22 days ago
Actinium Pharmaceuticals IncATNM
30Buy$4.00+154.78%Reiterates
22 days ago
Lineage Cell Therapeutics IncLCTX
12Buy$9.00+741.12%Reiterates
23 days ago
Moleculin Biotech IncMBRX
2Buy$4.00+534.92%Reiterates
a month ago
Esperion Therapeutics IncESPR
28Buy$16.00+1,255.93%Reiterates
a month ago
Galectin Therapeutics IncGALT
1Buy$6.00+110.53%Assumes
a month ago
Biolinerx LtdBLRX
13Buy$26.00+453.19%Reiterates
a month ago
Celldex Therapeutics IncCLDX
34Buy$50.00+114.04%Reiterates
a month ago
Astria Therapeutics IncATXS
21Buy$16.00+141.69%Reiterates
a month ago
Gri Bio IncGRI
3Buy$10.00+440.54%Reiterates
a month ago
Atyr Pharma IncATYR
23Buy$35.00+532.91%Reiterates
a month ago
Xoma Royalty CorpXOMA
24Buy$104.00+274.64%Reiterates
2 months ago
Armata Pharmaceuticals IncARMP
15Buy$9.00+293.01%Maintains
2 months ago
Curis IncCRIS
1Buy$17.00+804.26%Assumes
2 months ago
Cadrenal Therapeutics IncCVKD
5Buy$32.00+156.00%Reiterates
2 months ago
Biomx IncPHGE
14Buy$15.00+3,396.50%Maintains
2 months ago
Calcimedica IncCALC
12Buy$16.00+589.66%Reiterates
2 months ago
Fibrogen IncFGEN
3Buy$250.00+3,150.98%Reiterates
2 months ago
Iovance Biotherapeutics IncIOVA
25Buy$20.00+895.02%Maintains
2 months ago
Iterum Therapeutics PLCITRM
1Buy$9.00+800.00%Assumes
2 months ago
Biomea Fusion IncBMEA
29Buy$18.00+827.84%Maintains
2 months ago
Nuvectis Pharma IncNVCT
8Buy$15.00+82.48%Reiterates
3 months ago
Kura Oncology IncKURA
21Buy$40.00+529.92%Reiterates
3 months ago
Vyne Therapeutics IncVYNE
20Buy$4.50+238.35%Maintains
3 months ago
Tenaya Therapeutics IncTNYA
16Buy$5.00+603.23%Reiterates
3 months ago
Compass Therapeutics IncCMPX
18Buy$24.00+721.92%Reiterates
3 months ago
Cytokinetics IncCYTK
44Buy$120.00+211.04%Reiterates
3 months ago
Tempest Therapeutics IncTPST
19Hold$16.00+131.88%Downgrades
3 months ago
Clene IncCLNN
29Buy$31.00+731.10%Reiterates
3 months ago
Kairos Pharma LtdKAPA
1Buy$12.00+1,651.82%Initiates Coverage On
3 months ago
Aptose Biosciences IncAPTOF
15Buy$6.00+250.88%Maintains
4 months ago
Pharming Group NvPHAR
17Buy$37.00+257.49%Reiterates
4 months ago
Omniab IncOABI
7Buy$11.00+436.59%Reiterates
4 months ago
Checkpoint Therapeutics IncCKPT
17Hold$4.10-3.76%Downgrades
4 months ago
Rigel Pharmaceuticals IncRIGL
22Buy$57.00+194.57%Reiterates
4 months ago
Palatin Technologies IncPTNT
27Buy$7.00+7,042.86%Maintains
5 months ago
Neuphoria Therapeutics IncNEUP
7Buy$21.00+172.73%Maintains
5 months ago
Aprea Therapeutics IncAPRE
14Buy$20.00+1,076.47%Reiterates
6 months ago
Biocardia IncBCDA
15Buy$25.00+972.96%Reiterates
7 months ago
Lisata Therapeutics IncLSTA
17Buy$15.00+470.34%Reiterates
7 months ago
Fortress Biotech IncFBIO
2Buy$26.00+1,226.53%Maintains
8 months ago
Adlai Nortye LtdANL
3Buy$9.00+496.03%Reiterates
8 months ago
Ligand Pharmaceuticals IncLGND
18Buy$157.00+23.70%Reiterates
8 months ago
Genenta Science SpaGNTA
4Buy$25.00+561.38%Reiterates
9 months ago
Shattuck Labs IncSTTK
15Buy$16.00+1,851.22%Reiterates
a year ago
Biora Therapeutics IncBIOR
9Buy$150.00+26,685.71%Reiterates
a year ago
Mustang Bio IncMBIO
6Buy$100.00N/AReiterates
a year ago
Panbela Therapeutics IncPBLA
8Buy$5.00N/AMaintains
a year ago
Alpine Immune Sciences IncALPN
7Buy$50.00N/AMaintains
a year ago
Traws Pharma IncTRAW
9Buy$11.00N/AReiterates
2 years ago
Biophytis SaBPTSY
5Buy$600.00N/AReiterates
2 years ago
Decibel Therapeutics IncDBTX
5Buy$23.00N/AReiterates
2 years ago
Atreca IncBCEL
5Buy$25.00N/AReiterates
2 years ago
Aravive IncARAV
9Buy$12.00N/AReiterates
2 years ago
Xenetic Biosciences IncXBIO
3Buy$40.00N/AReiterates
2 years ago
IMV IncIMVIQ
1Buy$65.00N/AReiterates
2 years ago
Applied Genetic Technologies CorpAGTC
3HoldN/AN/ADowngrades
3 years ago
Akouos IncAKUS
2HoldN/AN/ADowngrades
3 years ago
Humanigen IncHGENQ
3HoldN/AN/ADowngrades
3 years ago
Genocea Biosciences IncGNCAQ
2HoldN/AN/ADowngrades
3 years ago
Sierra Oncology IncSRRA
1Hold$55.00N/ADowngrades
3 years ago
Sio Gene Therapies IncSIOX
3Buy$7.00N/AMaintains
3 years ago
Beyondspring IncBYSI
4HoldN/AN/ADowngrades
4 years ago
Essa Pharma IncEPIX
3Buy$32.00N/AMaintains
4 years ago
Strata Skin Sciences IncSSKN
1Buy$30.00N/AUpgrades
5 years ago
Principia Biopharma IncPRNB
4Hold$100.00N/ADowngrades
5 years ago
Avid Bioservices IncCDMO
2Buy$9.00N/AReiterates
5 years ago
Immune Design CorpIMDZ
1Buy$7.75N/AMaintains
7 years ago
Tg Therapeutics IncTGTX
2Buy$33.00N/AAssumes
8 years ago
Soligenix IncSNGX
1Buy$2,640.00N/AInitiates Coverage On
8 years ago
Palvella Therapeutics IncPVLA
1Strong Buy$720.00N/AInitiates Coverage On
8 years ago
Verastem IncVSTM
1Buy$78.00N/AReiterates
8 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.